Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib--a Swedish model application (Q42976135)
Jump to navigation
Jump to search
scientific article published on August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib--a Swedish model application |
scientific article published on August 2010 |
Statements
1 reference
Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib--a Swedish model application (English)
1 reference
Ola Ghatnekar
1 reference
Frida Hjalte
1 reference
Matthew Taylor
1 reference
1 August 2010
1 reference
1 reference
49
1 reference
6
1 reference
851-858
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference